Literature DB >> 19564367

Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9.

Samy Figueiredo, Laurent Poirel, Anna Papa, Vassiliki Koulourida, Patrice Nordmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19564367      PMCID： PMC2737879          DOI： 10.1128/AAC.00292-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

Review 2.  Acinetobacter infection.

Authors:  L Silvia Munoz-Price; Robert A Weinstein
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

3.  Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Pierre-Edouard Fournier; Jean-Michel Claverie; Didier Raoult; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.

Authors:  L Poirel; E Lebessi; C Héritier; A Patsoura; M Foustoukou; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2006-11       Impact factor: 8.067

7.  Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.

Authors:  Anaïs Potron; Laurent Poirel; Jacques Croizé; Vanessa Chanteperdrix; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

8.  High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.

Authors:  M Ruiz; S Marti; F Fernandez-Cuenca; A Pascual; J Vila
Journal:  Clin Microbiol Infect       Date:  2007-09-10       Impact factor: 8.067

9.  Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.

Authors:  A Tsakris; A Ikonomidis; A Poulou; N Spanakis; D Vrizas; M Diomidous; S Pournaras; F Markou
Journal:  Clin Microbiol Infect       Date:  2008-04-05       Impact factor: 8.067

10.  Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital.

Authors:  Laurent Poirel; Olivier Menuteau; Nathalie Agoli; Christian Cattoen; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948
View more
  24 in total

Review 1.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

2.  Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii.

Authors:  Jennifer H Moffatt; Marina Harper; Ben Adler; Roger L Nation; Jian Li; John D Boyce
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

3.  Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identification of structures related to its susceptibility phenotype.

Authors:  Maria Soledad Ramirez; Mark D Adams; Robert A Bonomo; Daniela Centrón; Marcelo E Tolmasky
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae.

Authors:  Rémy A Bonnin; Alain A Ocampo-Sosa; Laurent Poirel; Hélène Guet-Revillet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

5.  OXA-134, a naturally occurring carbapenem-hydrolyzing class D beta-lactamase from Acinetobacter lwoffii.

Authors:  Samy Figueiredo; Laurent Poirel; Harald Seifert; Pauline Mugnier; Dan Benhamou; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2010-09-13       Impact factor: 5.191

Review 6.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

7.  OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii.

Authors:  Paul G Higgins; Laurent Poirel; Marlene Lehmann; Patrice Nordmann; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

8.  Distribution of allelic variants of the chromosomal gene bla OXA-114-like in Achromobacter xylosoxidans clinical isolates.

Authors:  German Matías Traglia; Marisa Almuzara; Andrea Karina Merkier; Mariana Papalia; Laura Galanternik; Marcela Radice; Carlos Vay; Daniela Centrón; María Soledad Ramírez
Journal:  Curr Microbiol       Date:  2013-06-15       Impact factor: 2.188

9.  Transposition of Tn125 Encoding the NDM-1 Carbapenemase in Acinetobacter baumannii.

Authors:  Séverine Bontron; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 10.  Genomic epidemiology of multidrug-resistant Gram-negative organisms.

Authors:  Shawn E Hawken; Evan S Snitkin
Journal:  Ann N Y Acad Sci       Date:  2018-03-31       Impact factor: 5.691
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.